AcuityMD Introduces ‘Care Journeys’ for Medtech Companies

AcuityMD, a leading technology provider to the medtech industry, launched AcuityMD Care Journeys to help medtech companies efficiently bring their innovations to the right patients by harnessing longitudinal, patient-level data for more precise targeting. 
 
Care Journeys help medtech teams accurately identify patient populations that can benefit the most from their innovations – especially groups with comorbidities, dual diagnoses, or at the intersection of multiple conditions and procedures.
 
Care Journeys also empowers commercial teams to demonstrate the value of their products to physicians, hospitals, and independent delivery networks (IDNs), driving revenue and improving patient care.
 
“More precision in targeting ultimately results in a higher-quality sales pipeline, which supports the entire MedTech commercialization process,” said Ross Feinstein, vice president of product at AcuityMD. “Care Journeys makes it fast and easy to not only pinpoint complex patient populations, but also harness clinical market share, patient data, and quality of care insights to become trusted advisors to providers, ultimately improving patient care.”
 
icotec Medical makes a unique carbon composite surgical screw for patients suffering from metastatic spine disease. These radiolucent, non-metallic screws produce little-to-no artifacts in diagnostic imaging such as computer tomography (CT) scans and magnetic resonance imaging (MRI), which leads to safer delivery of adjuvant radiation therapy and improved monitoring and follow-up care. 
 
Icotec uses Care Journeys to uncover sites of care that treat patients with spinal tumors and spine surgeons and radiation oncologists that treat them. The company has leveraged Care Journeys to create a commercialization strategy, inform decisions on headcount and manufacturing, identify partner sites of care, and more in preparation for launch.
 
Scott McKay, product manager at icotec Medical commented, “Care Journeys enables our organization to quickly identify the appropriate patient population in target accounts and the key stakeholders in each of those sites of care that we have been struggling to find for years. Care Journeys’ insights also enrich our partnership with surgeons and healthcare systems, empowering us to bring more value to our partners and help them identify and treat more patients with our unique technology.”
 
Synchron Inc. is leveraging Care Journeys to identify and enroll patients in a pre-clinical trial for its brain-computer interface (BCI) that allows paralyzed patients to control digital outputs, providing a breakthrough treatment for Amyotrophic Lateral Sclerosis (ALS) patients. With the next trial starting in 2025, Synchron faced challenges in identifying the right ALS patients for trial participation. 
 
“As we gear up for the BCI trial, AcuityMD Care Journeys’ insights into this specific ALS patient population, treatment centers, key stakeholders, and potential referrals has been invaluable,” said John McKinley, senior director of medical education and training at Synchron. “Care Journeys’ multidimensional data is expanding our search beyond existing connections to new geographies and has helped us quickly hone in on viable clinical trial sites. This intelligence will also be critical to our post-approval commercialization strategy.”